Salivary gland ultrasound abnormalities in primary Sjögren's syndrome::consensual US-SG core items definition and reliability by Jousse-Joulin, Sandrine et al.
 
 
University of Birmingham
Salivary gland ultrasound abnormalities in primary
Sjögren's syndrome:
Jousse-Joulin, Sandrine; Nowak, Emmanuel; Cornec, Divi; Brown, Jackie; Carr, Andrew;
Carotti, Marina; Fisher, Benjamin; Fradin, Joel; Hocevar, Alojzija; Jonsson, Malin V; Luciano,
Nicoletta; Milic, Vera; Rout, John; Theander, Elke; Stel, Aaltje; Bootsma, Hendrika; Vissink,
Arjan; Baldini, Chiara; Baer, Alan; Ng, Wan Fai
DOI:
10.1136/rmdopen-2016-000364
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Jousse-Joulin, S, Nowak, E, Cornec, D, Brown, J, Carr, A, Carotti, M, Fisher, B, Fradin, J, Hocevar, A, Jonsson,
MV, Luciano, N, Milic, V, Rout, J, Theander, E, Stel, A, Bootsma, H, Vissink, A, Baldini, C, Baer, A, Ng, WF,
Bowman, S, Alavi, Z, Saraux, A & Devauchelle-Pensec, V 2017, 'Salivary gland ultrasound abnormalities in
primary Sjögren's syndrome: consensual US-SG core items definition and reliability', RMD Open, vol. 3, no. 1,
e000364. https://doi.org/10.1136/rmdopen-2016-000364
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Article was published in RMD Open on 01/06/2017
doi: 10.1136/rmdopen-2016-000364
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
  1Jousse-Joulin S, et al. RMD Open 2017;3:e000364. doi:10.1136/rmdopen-2016-000364
Original article
Salivary gland ultrasound abnormalities 
in primary Sjögren’s syndrome: 
consensual US-SG core items definition 
and reliability
Sandrine Jousse-Joulin,1 Emmanuel Nowak,2 Divi Cornec,1 Jackie Brown,3 
Andrew Carr,4 Marina Carotti,5 Benjamin Fisher,6,7 Joel Fradin,8 Alojzija Hocevar,9 
Malin V Jonsson,10 Nicoletta Luciano,11 Vera Milic,12 John Rout,13 Elke Theander,14 
Aaltje Stel,15 Hendrika Bootsma,15 Arjan Vissink,16 Chiara Baldini,11 
Alan Baer,17 Wan Fai Ng,18 Simon Bowman,7 Zarrin Alavi,2 Alain Saraux,1 
Valérie Devauchelle-Pensec1
To cite: Jousse-Joulin S, 
Nowak E, Cornec D, et al. 
Salivary gland ultrasound 
abnormalities in primary 
Sjögren’s syndrome: consensual 
US-SG core items definition 
and reliability. RMD Open 
2017;3:e000364. doi:10.1136/
rmdopen-2016-000364
 ► Prepublication history and 
additional material are available. 
To view please visit the journal 
(http:// dx. doi. org/ 10. 1136/ 
rmdopen- 2016- 000364).
Received 14 September 2016
Revised 6 February 2017
Accepted 14 February 2017
For numbered affiliations see 
end of article.
Correspondence to
Dr Valérie Devauchelle-Pensec;  
 valerie. devauchelle- pensec@ 
chu- brest. fr
Sjögren syndrome
AbstrAct
Objectives Ultrasonography (US) is sensitive for detecting 
echostructural abnormalities of the major salivary 
glands (SGs) in primary Sjögren’s syndrome (pSS). Our 
objectives were to define selected US-SG echostructural 
abnormalities in pSS, set up a preliminary atlas of these 
definitions and evaluate the consensual definitions 
reliability in both static and acquisition US-SG images.
Methods International experts in SG US in pSS 
participated in consensus meetings to select and define 
echostructural abnormalities in pSS. The US reliability 
of detecting these abnormalities was assessed using 
a two-step method. First 12 experts used a web-
based standardised form to evaluate 60 static US-SG 
images. Intra observer and interobserver reliabilities 
were expressed in κ values. Second, five experts, who 
participated all throughout the study, evaluated US-SG 
acquisition interobserver reliability in pSS patients.
Results Parotid glands (PGs) and submandibular glands 
(SMGs) intra observer US reliability on static images was 
substantial (κ > 0.60) for the two main reliable items 
(echogenicity and homogeneity) and for the advised pSS 
diagnosis. PG inter observer reliability was substantial for 
homogeneity. SMGs interobserver reliability was moderate 
for homogeneity (κ = 0.46) and fair for echogenicity (κ = 
0.38). On acquisition images, PGs interobserver reliability was 
substantial (κ = 0.62) for echogenicity and moderate (κ = 
0.52) for homogeneity. The advised pSS diagnosis reliability 
was substantial (κ = 0.66). SMGs interobserver reliability was 
fair (0.20< κ ≤ 0.40) for echogenicity and homogeneity and 
either slight or poor for all other US core items.
Conclusion This work identified two most reliable US-SG 
items (echogenicity and homogeneity) to be used by US-SG 
trained experts. US-PG interobserver reliability result for 
echogenicity is in line with diagnosis of pSS.
IntroductIon
Lymphocytic infiltration of the salivary glands 
(SGs) is a key pathological feature of primary 
Sjögren’s syndrome (pSS).1 2 Currently 
available tools for assessing the SGs include 
salivary flow measurement, minor SG biopsy, 
sialography, scintigraphy, CT and MRI. 
Ultrasonography (US) was introduced more 
recently.3–7 US holds considerable appeal, as 
it is non-invasive, does not involve ionising 
radiation, can be repeated many times and is 
available as an outpatient investigation. Both 
researchers and clinicians have identified US 
as a valuable tool for diagnosing pSS8–15 and 
as a potential source of classification criteria 
for this disease. Moreover, the advent of new 
treatments for pSS16 has created a need for 
valid and easy-to-use imaging tools capable 
of detecting changes in disease activity over 
Key messages
What is already known about this subject?
 ► Diagnosis of primary Sjögren’s syndrome (pSS) is a 
challenge.
 ► Ultrasound of salivary glands (US-SG) is a valuable 
diagnostic tool.
 ► Yet there is no gold standard of US diagnosis for 
echostructural abnormalities in pSS.
What does this study add?
 ► This work put forward a preliminary atlas of 
echostructural abnormalities in pSS.
 ► This work identified two most reliable US-SG items: 
echogenicity and homogeneity.
How might this impact on clinical practice?
 ► Trained US-SG experts can use our preliminary atlas 
of US-SG abnormalities.
 ► This can be done concomitantly with other 
classification criteria in diagnosis of pSS.
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time.17 Using the Outcome Measures in Rheumatology 
(OMERACT) filter,18 we recently reported the need for a 
consensual scoring system, SG US expert training as well 
as evaluation of US criterion validity, that is, comparing 
minor SG biopsy to minor SG US.19 The review results 
were consistent with those of the literature20–25 and our 
review is the first step in setting up an OMERACT stan-
dard that will open further avenues for the use of such 
promising diagnostic tool.26 Today, US cannot yet be 
used as the sole diagnostic bedside tool in pSS but as an 
early diagnostic tool when used carefully by experienced 
US experts.
Here, our objectives were to define selected US-SG 
echostructural abnormalities in pSS, set up a preliminary 
atlas of these definitions and evaluate the consensual 
definitions reliability in both static and acquisition US-SG 
images.
Method
definition of the core items of ultrasound sGs
During the 2012 American Congress of Rheumatology 
meeting, international pSS experts (from France, Norway, 
Italy, England, Serbia, Slovenia, Sweden, The Nether-
lands and USA) who had at least 5 years of experience 
with US in pSS were invited to work on the study. Among 
10 experts, only 6 contributed to the first meeting towards 
achieving a consensus definition of US-SG abnormalities 
in pSS. They selected a preliminary core set of US-SG 
items worthy of routine evaluation. These experts then 
completed an email questionnaire, indicating whether 
they agreed with each definition (yes/no answers). The 
same six experts followed up to the 2013 and 2014 Euro-
pean League of Rheumatism (EULAR) meetings where 
preliminary 2012 meeting results were presented.
set-up of a sG ultrasound atlas
Finally, in 2014 consensus was reached in regard with the 
US-SG core items and a preliminary atlas was set forth.
This initial atlas included only consensual B-mode 
images in pSS and will be used by the experts.
reliability of us-sG core items on static us images
Twelve experts performed a web-based standardised 
form (table 1) to evaluate 60 static images (30 parotid 
glands (PGs) and 30 submandibular glands (SMGs)) 
(Philips iU22, 12.5 MHz linear array transducer; Philips 
Healthcare, Amsterdam, The Netherlands). The set 
of B-mode images (with the same setting) of the major 
SGs, from Brest centre data bank, of patients with pSS 
and normal individuals was chosen in order to have both 
images of normal (healthy individuals) and abnormal SG 
parenchymal echostructure (pSS patients) and were sent 
to other centres. Each expert evaluated the items selected 
Table 1 Standardised form used to assess the reliability of ultrasound of salivary gland core items of the images
Parotid glands Submandibular glands
Right Left Right Left
Echogenicity
  Normal, (0); Abnormal (fibrosis), 1
 Homogeneity
  Normal, 0; Abnormal, 1
Hyperechoic bands
  None (0), <50% of the parenchyma (1), ≥50% (2)
Number of hypoechoic/anechoic areas*
Size of the largest hypoechoic/anechoic area (mm)*
Location of the hypoechoic/anechoic areas in the gland
  None (0), isolated (<25% of the surface area) (1), localised (25%–
50%) (2), scattered (>50%) (3), diffused (4)
  Number of abnormal lymph nodes in the glands*
  Presence of normal lymph nodes at the upper and/or lower poles of 
the parotid glands: no (0), yes (1)
Calcifications
  No (0), yes (1)
Posterior border visible
  No (0), yes  (1)
Diagnosis advice of pSS based on the seven items
   ruled out (0), indeterminate (1), ruled in (2)
*Quantitative variables were then categorised as follows: number of hypoechoic/anechoic areas: None (0), 1–4 (1), ≥5 (2); size of the largest 
area: None (0), ≤2 (1), >2 (2); abnormal lymph nodes: No (0), Yes (1).
pSS, primary Sjögren’s syndrome.
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by consensus (ie, the preliminary atlas) in two rounds, 
at an interval of 3 months. Then an advice for pSS diag-
nosis (rule out, rule in, indeterminate) was given by the 
experts. The results were used to assess interobserver and 
intraobserver reliabilities. All images were read anony-
mously and in random order.
reliability of us-sG core items on acquisition imaging in 
patients with pss
Five experts, of the initial six who participated in devel-
opment of the definitions and the atlas, participated in 
assessment of the reliability of the consensual items in 
acquisition imaging. Over a 2-day period, each expert 
performed US of both PGs and both SMGs of 19 patients 
with pSS (with or without known SG abnormalities). 
Various US machines were used (Mylab ALPHA, Mylab60 
and Mylab 6; all from Esaote, Genoa, Italy). Given the differ-
ence in each patient’s SG echogenicity US B-mode settings 
were adjusted according to each patient. The time needed 
for each expert to examine the 19 patients was recorded. 
Approval was obtained from Brest ethics committee and 
the study was referred in clinical trial (NCT 02358213).
statistical analysis
Cohen’s κ was used to measure interobserver agreement for 
binary items. Weighted κ (Fleiss-Cohen weights) was used 
for items with more than two ordinal categories.27 κ coef-
ficients were calculated for each pair of observers, leading 
to mean value, minimum and maximum for each item. 
The same coefficients were calculated for each observer to 
measure intraobserver agreement between the first and the 
second interpretation, leading to mean value, minimum 
and maximum for each US-SG core item.28
Number of hypoechoic or anechoic areas was recorded 
as: none, 1–4 or ≥5 and location was reported as follows: 
none, isolated, localised, scattered or diffuse. Number 
of abnormal lymph nodes was recorded as present or 
absent. Diagnosis advice was reported as follows: ruled 
out, indeterminate or ruled-in.
According to Landis and Koch,29  κ values were inter-
preted as follows: <0.00 poor, 0.00–0.20 slight, 0.21–0.40 
fair, 0.41–0.60 moderate, 0.61–0.80 substantial and 0.81–
1.00 almost perfect.
results
definition of us-sG echostructural abnormalities (us-sG 
core items)
The experts selected the US-SG echostructural abnor-
malities related to: echogenicity, homogeneity, lymph 
nodes, posterior border, in B-mode (see online supple-
mentary table 1). The definitions developed during the 
first meeting were modified during the second meeting 
(see online supplementary table 1). Complete agree-
ment was reached about the following items definitions: 
echogenicity, homogeneity, lymph nodes, posterior 
border, calcification, hyperechoic bands, hypoechoic/
anechoic areas, location of hypoechoic/anechoic areas 
and abnormal lymph nodes. We called these items US-SG 
core items. An initial consensual reference atlas (33 
consensual images) was developed based on these defini-
tions (figure 1 and see online supplementary atlas).
reliability of sG ultrasound core items using static images
intraobserver reliability
PG intraobserver US reliability was substantial for: echoge-
nicity, homogeneity, number and location of hypoechoic/
anechoic areas, and normal lymph nodes. The advised pSS 
diagnosis reliability was substantial (κ=0.86) (table 2). In 
contrast, intraobserver reliability was moderate for hypere-
choic bands, number of abnormal lymph nodes, and fair for 
calcifications, posterior border visibility.
SMG intraobserver US reliability was substantial 
for echogenicity, homogeneity, hyperechoic band, 
hypoechoic/anechoic areas and location. The results 
were moderate for normal lymph nodes, calcification 
and posterior border. The advised diagnosis reliability 
was substantial (κ=0.70).
interobserver reliability
PG interobserver reliability was substantial for homoge-
neity, number and location of hypoechoic/anechoic areas 
and moderate for echogenicity and normal lymph nodes. 
The results were fair for hyperechoic bands and slight for 
calcification and posterior border. The advised diagnosis 
reliability was substantial (κ=0.78). SMG interobserver 
reliability was fair for echogenicity and calcification. The 
results were: moderate for homogeneity, hypoechoic/
anechoic areas and location; slight for posterior border 
and normal lymph nodes. Advised diagnosis reliability 
was moderate (κ=0.54).
distribution of ultrasound core items for static images
Item distributions were similar between the two readings. 
Echogenicity was regarded as normal in >50% of both PGs 
and SMGs. Homogeneity was regarded as abnormal in >50% 
of the SMGs and 48.6%–52.1% of the PGs. Hyperechoic 
bands occupying <50% of the gland surface area of both 
PGs and SMGs were seen in >50% of the cases (table 3). In 
all four SGs, hypoechoic/anechoic areas were not found 
in 44.9%–53.1% of cases, and ≥5 hypoechoic areas were 
found in 23.9%–33.0% of the cases. Normal-appearing 
lymph nodes were seen in >20% of PGs and <10% of SMGs. 
Abnormal lymph nodes and calcifications were rare in both 
PGs and SMGs. The posterior border was usually not visible, 
particularly for the SMGs.
reliability of sG ultrasound core items on acquisition 
imaging
PGs interobserver reliability was substantial for echoge-
nicity and moderate for homogeneity, number and location 
and the size of the largest hypoechoic/anechoic area but 
fair for hyperechoic bands and slight for normal lymph 
nodes, number of abnormal lymph nodes, calcification and 
posterior border visibility (table 4). The advised diagnosis 
reliability of pSS was substantial (κ=0.66). SMGs interob-
server reliability was fair for echogenicity, homogeneity 
and number and location of hypoechoic/anechoic areas. 
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The results were slight for normal lymph nodes, calcifi-
cations and posterior border visibility. Advised diagnosis 
reliability was fair (κ=0.38).
As shown in table 5, mean time duration of US ranged 
across observers from 11 to 27 min.
dIscussIon
Given the multitude of US-SG abnormalities in pSS, it has 
become a challenge to reach consensus on the definition 
and scoring of the most reliable US-SG abnormalities.19 
We conducted this study to develop an international 
consensus about the definitions of echostructural 
abnormalities of SG in pSS and to evaluate the reliability 
of US in detecting them.
Homogeneity and echogenicity items showed substan-
tial intraobserver reliability for both PGs and SMGs 
on static images. Whereas interobserver reliability of 
homogeneity was only substantial in PGs and moderate 
in SMGs and that of echogenicity was moderate in PGs 
and fair again in SMGs. Heterogeneity was defined as the 
presence of hypoechoic/anechoic areas with or without 
hyperechoic bands. For both glands, there is an abun-
dance of hypoechoic/anechoic areas in pSS and their 
absence in normal individuals. However, the presence 
Figure 1 The  core items were (A) hypoechogenicity, (B) heterogeneity (numerous anechoic areas), (C) hyperechoic bands, (D) 
calcifications (star), (E) lymph nodes (white arrow), (F) anechoic area, (A, D,E,F) posterior border (dotted line).
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of highly vascularised fatty infiltration (ie, SMG echotex-
ture vs PG echotexture) in SMGs may contribute to 
the difference observed in interobserver reliabilities of 
homogeneity item. These findings are consistent with 
those reported by Yoshiura et al.7
In line with previous studies,7 30 several core items 
showed low reliability in our study, namely, hyperechoic 
bands, calcifications and posterior border visibility for PGs 
and SMGs. Even though hyperechoic bands were defined 
by consensus, their reliable assessment in pSS remains 
challenging. Hyperechoic bands may develop in normal 
individuals due to advanced age or fibrosis of the SGs.
The static image inter-reliability of lymph nodes was 
moderate for the PGs but only slight for the SMGs, a 
Table 3 Distribution of ultrasound items for static images
Parotid glands Submandibular glands
First reading Second reading First reading Second reading
Echogenicity
  Normal 58.9% 57.4% 59.6% 58.1%
  Abnormal 41.1% 42.6% 40.4% 41.9%
Homogeneity
  Normal 51.4% 47.9% 47.5% 45.1%
  Abnormal 48.6% 52.1% 52.5% 54.9%
Hyperechoic bands
  None 36.1% 36.5% 42.8% 41.5%
  <50% 51.9% 52.1% 54.2% 52.7%
  ≥50% 11.9% 11.4% 3.1% 5.9%
Number of hypoechoic/anechoic areas
  None 53.1% 48.2% 49.7% 44.9%
  1–4 14.2% 18.8% 26.4% 28.5%
  ≥5 32.7% 33% 23.9% 26.6%
Location of hypoechoic/anechoic areas
  None 51.4% 47.3% 49.0% 44.7%
  Isolated 11.9% 14.8% 21.2% 20.8%
  Localised 10.0% 16.4% 12.5% 14.9%
  Scattered 6.4% 3.9% 5.0% 4.8%
  Diffuse 20.3% 17.5% 12.3% 14.9%
Normal nodes
  No 73.6% 73.3% 92.5% 93.6%
  Yes 26.4% 26.7% 7.5% 6.4%
Abnormal nodes
  No 93.3% 94.7% 98.0% 98.6%
  Yes 6.7% 5.3% 2.0% 1.4%
Calcifications
  No 86.1% 86.6% 83.8% 86.0%
  Yes 13.9% 13.4% 16.2% 14.0%
Posterior border visible 
  No 41.9% 45.0% 17.0% 22.0%
  Yes 58.1% 55.0% 83.0% 78.0%
pSS diagnosis advice*
  Ruled out 55.8% 51.4% 55.8% 50.4%
  Indeterminate 9.7% 12.8% 11.9% 16.8%
  Ruled in 34.4% 35.7% 32.2% 32.8%
*Diagnosis advice was given in regard with the typical pattern of pSS on images and not in patients with pSS.
pSS, primary Sjögren’s syndrome.
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finding that may reflect the usual absence of visible 
lymph nodes in the SMGs7 31 and their usual presence at 
specific locations in the PGs. Despite the definition estab-
lished by consensus, calcifications were also difficult to 
assess. This finding may be ascribable to technical factors: 
when using static images, image quality cannot be opti-
mised (for instance by changing the scanned area) and 
calcifications may be mistaken for hyperechoic bands. 
None of the nine published studies on the interobserver 
reliability of SG US in pSS7 10 15 20 25 30 32–35 evaluated calci-
fications. The posterior border was also difficult to assess, 
particularly for PGs, due to their anatomy and location in 
the retromandibular fossa.32 In our study, both PGs and 
SMGs inter-reliability and intrareliability were moderate 
to substantial for echogenicity and homogeneity (echo-
structure) due to the presence and distribution of 
hypoechoic/anechoic areas. 
In the acquisition imaging study in 19 patients with pSS, 
homogeneity item showed moderate interobserver reli-
ability for PGs and fair for SMGs. Whereas the results for 
echogenicity item of PG and SMG were substantial and fair, 
respectively. Our results contradict a single-centre study by 
Carotti et al,10 who reported better reliability for SMGs than 
for PGs. Nevertheless, moderate interobserver reliability 
for PG homogeneity and fair one for SMG were consistent 
with those of the literature.36–38
In our study, the experts’ advised diagnosis of pSS on 
static US images showed substantial interobserver and 
intraobserver reliability for PGs and intraobserver reli-
ability for SMGs. Experts’ advised diagnosis of pSS on 
acquisition US showed substantial interobserver reli-
ability for PGs and fair for SMGs. These results may be 
explained by the better echogenicity of PGs compared 
with SMGs. These findings can be ascribed to the develop-
ment of a novel US atlas as a prerequisite to performing 
careful ultrasound evaluations by trained US experts of 
the SGs in patients with pSS.39
Our study had several limitations. First limitation was 
the small number of US experts and US acquisitions 
performed, which precluded a large-scale Delphi.36 40
However, pSS is not a so common disease41 42 and, 
consequently, few experts were trained in SG US at 
the time of the study. Second, different US machines 
were used for acquisition in pSS patients, that is, not all 
experts had prior training with the proposed machines. 
In addition, intraobserver reliability of US-SG core 
items was not evaluated due to the lack of time during 
our study. Another limitation was that the interobserver 
reliability of abnormal lymph nodes could not be eval-
uated yet can be explained by the rare nature of this 
US-SG item in pSS. Our study drawback is the fact that 
Table 4 Interobserver reliability of image acquisition: 
κ values for ultrasound items in the parotid and 
submandibular glands
Item PG SMG
Echogenicity
  Mean 0.62 0.28
  Min–Max 0.42–1.00 0.00–0.58
Homogeneity
  Mean 0.52 0.26
  Min–Max 0.16–0.87 −0.05 to 0.87
Hyperechoic bands
  Mean 0.38 0.19
  Min–Max 0.11–0.64 −0.09 to 0.39
Number of hypoechoic/anechoic areas*
  Mean 0.54 0.27
  Min–Max 0.34–0.88 0.09–0.51
Size of the largest hypoechoic/anechoic area*
  Mean 0.41 0.17
  Min–Max 0.29–0.79 0.04–0.41
Location of hypoechoic/anechoic areas
  Mean 0.58 0.30
  Min–Max 0.26–0.85 0.08–0.65
Number of abnormal lymph nodes *
  Mean – –
  Min–Max – –
Normal lymph nodes
  Mean 0.13 0.01
  Min–Max −0.07 to 0.28 −0.09 to 0.26
Calcifications
  Mean 0.03 0.03
  Min–Max −0.05 to 0.37 −0.10 to 0.19
Posterior border visibility
  Mean 0.02 0.15
  Min–Max −0.16 to 0.18 0.00–0.48
Diagnosis advice*
  Mean 0.66 0.38
  Min–Max 0.30–0.97 0.12–0.65
Quantitative variables were then categorised as follows: number 
of hypoechoic/anechoic areas: None (0), 1–4 (1),≥5 (2); size of the 
largest area: None (0), ≤2 (1), >2 (2); abnormal lymph nodes: No 
(0), Yes (1).
*Diagnosis advice was given in regard with the typical pattern of 
pSS on images and not in patients with pSS.
PG, parotid gland; pSS, primary Sjögren’s syndrome; SMG, 
submandibular gland.
Table 5 Time in minutes needed by each observer to 
perform salivary gland ultrasonography
Observer Min Mean Median Max
A 8 11.4 11 16
B 16 27 26 36
C 15 23 23 40
D 7 12 12 15
E 13 18.8 18 27
group.bmj.com on October 26, 2017 - Published by http://rmdopen.bmj.com/Downloaded from 
8 Jousse-Joulin S, et al. RMD Open 2017;3:e000364. doi:10.1136/rmdopen-2016-000364
RMD Open
the images (both in static and in acquisition mode) 
were not characteristic of patients seen in consultation 
for a suspicion of pSS. The assessment of the abnormal 
echostructure (ie, typical pattern of an inhomoge-
neous gland with hypoechoic/anechoic areas in its 
parenchyma) of the images led to the ‘advised diag-
nosis’ by experts. We did not perform a diagnosis of 
pSS patients. The typical pattern is a conclusive charac-
teristic of pSS but not present in all pSS patients.
In conclusion, this study is the first attempt to set forth 
a preliminary atlas of consensual US images and US-SG 
core items definitions. We assessed the reliability of 
US-SG core items of the images in regard with the typical 
pattern of an inhomogeneous gland with hypoechoic/
anechoic areas in its parenchyma, (ie, not present in 
all pSS patients) to identify those most reliable. The 
reliability results of the pSS typical pattern on these 
images can be used carefully by US-SG trained experts 
and concomitantly with other classification criteria in 
diagnosis of pSS. US-PG interobserver reliability result 
(substantial) for echogenicity seems to be in line with 
that of advised diagnosis of pSS.
Larger sample US-SG acquisition studies using the same 
US machine by US-SG trained experts are warranted to 
validate our results and to further evaluate intraobserver 
reliability of US-SG items. Our US-SMG reliability results 
open the avenue to further search for other reliable and 
relevant abnormality definitions and scorings of SMG 
echotexture—to better distinguish them from neigh-
bouring tissues.
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